Clinical trial
Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery
NCT03541928
Study timeline
Study start (actual)2018-08-02Date precision: day
Registry last updated2021-04-06
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
High-risk Prostate Cancerunresolved
Prostate Cancerunresolved
Interventions
HSV-TkDRUG
ValacyclovirDRUG · verified · RxNorm: valacyclovir
BicalutamideDRUG · verified · RxNorm: bicalutamide
Leuprolide AcetateDRUG · verified · RxNorm: leuprolide acetate
Radical prostatectomyPROCEDURE
Sponsors & collaborators
The Methodist Hospital Research Institutelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03541928 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.